Availability and geographic access to breast cancer pathology services in Ghana
Open Access
- 14 August 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0305901
Abstract
Introduction: Breast cancer poses a significant health challenge in Sub-Saharan Africa, particularly in Ghana, where late-stage diagnoses and limited healthcare access contribute to elevated mortality rates. This study focuses on the crucial role of pathology and laboratory medical (PALM) services in the timely diagnosis of breast cancer within Ghana. Methods: A cross-sectional survey of hospitals was completed from November 2020 to October 2021, with 94.8% of identified in-country hospitals participating. Pathology service-related parameters assessed included whether pathology was available for the diagnosis of breast cancer on-site or via external referral, the number of pathology personnel, additional breast cancer diagnostic capabilities including estrogen and progesterone and/or HER2 testing, and the time from biopsy to patients receiving their results. Geospatial mapping was used to identify areas of limited access. Results: Of the 328 participating hospitals, 136 (41%) reported breast cancer pathology services, with only 6 having on-site capabilities. Pathology personnel, comprising 15 consultants and 15 specialists, were concentrated in major referral centers, particularly in Greater Accra and Kumasi. An assessment of referral patterns suggested that 75% of the population reside within an hour of breast cancer pathology services. Among the 136 hospitals with access to breast cancer pathology, only a limited number reported that results included ER/PR (38%) and HER2 testing (33%). Conclusion: Ghana has been able to ensure significant pathology service availability through robust referral pathways with centralized labs. Despite this, difficulties persist with the majority of pathology results not including hormone receptor testing which is important in providing tumor specific treatment.Keywords
Funding Information
- National Cancer Institute (T32CA126607)
- Gardner & Holt
This publication has 28 references indexed in Scilit:
- Can pathology diagnostic services for cancer be stratified and serve global health?Cancer, 2020
- Breast cancer survival in sub‐Saharan Africa by age, stage at diagnosis and human development index: A population‐based registry studyInternational Journal of Cancer, 2019
- Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutionsThe Lancet, 2018
- Access to pathology and laboratory medicine services: a crucial gapThe Lancet, 2018
- Delivering modern, high-quality, affordable pathology and laboratory medicine to low-income and middle-income countries: a call to actionThe Lancet, 2018
- Delayed presentation and diagnosis of breast cancer in African women: a systematic reviewAnnals of Epidemiology, 2017
- The global burden of women’s cancers: a grand challenge in global healthThe Lancet, 2017
- Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysisThe Lancet Global Health, 2016
- Re-establishing a surgical pathology service in Kumasi, GhanaCancer, 2008
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005